Ordinary Rebalance | Solactive Transatlantic Healthcare Equity Index | Effective Date 10th January 2023
In the ordinary rebalance, the following index composition will be implemented effective open 10.01.2023:
3M COMPANY |
ABBOTT LABORATORIES |
ABBVIE INC |
ALCON INC |
AMGEN INC |
BAYER AG |
BECTON DICKINSON AND CO |
BIOMARIN PHARMACEUTICAL INC |
BIOMERIEUX |
BRISTOL-MYERS SQUIBB CO |
CIGNA CORP |
ELEVANCE HEALTH INC |
ELI LILLY & CO |
ENCOMPASS HEALTH CORP |
ENSIGN GROUP INC |
ESSILORLUXOTTICA |
GENMAB A/S |
GILEAD SCIENCES INC |
GSK PLC |
HAEMONETICS CORP |
HOLOGIC INC |
HUMANA INC |
INCYTE CORP |
IRONWOOD PHARMACEUTICALS INC |
JAZZ PHARMACEUTICALS PLC |
JOHNSON & JOHNSON |
LABORATORY CRP OF AMER HLDGS |
LHC GROUP INC |
MEDTRONIC PLC |
MERCK & CO. INC. |
MERCK KGAA |
MOLINA HEALTHCARE INC |
NEUROCRINE BIOSCIENCES INC |
NOVARTIS AG |
NOVO NORDISK A/S |
ORGANON & CO |
ORION OYJ CLASS B |
PFIZER INC |
PRESTIGE CONSUMER HEALTHCARE INC |
QIAGEN NV |
QUEST DIAGNOSTICS INC |
RESMED INC |
ROCHE HOLDING AG |
ROYALTY PHARMA PLC- CL A |
SANOFI SA |
STRYKER CORP |
UCB SA |
UNITED THERAPEUTICS CORP |
UNITEDHEALTH GROUP INC |
ZIMMER BIOMET HOLDINGS INC |